ライフサイエンスコーパス: lipoprotein receptor

1 hibits cholesterol uptake by the low-density lipoprotein receptor.

2 the host-cell receptor, lipolysis-stimulated lipoprotein receptor.

3 for lipoprotein lipase and very-low-density lipoprotein receptor.

4 oproteinase-9 pathway in pericytes through a lipoprotein receptor.

5 ligase IDOL as a negative regulator of brain lipoprotein receptors.

6 regulating neuronal migration by binding to lipoprotein receptors.

7 2 cm(2)+/-0.023 [n=9], P2X7(-/-) low density lipoprotein receptor(-/-) : 0.084 cm(2)+/-0.01 [n=11], P

8 domain (FIMAC), CD5 domain, and low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains.

9 g growth factor beta 1, oxidized low-density lipoprotein receptor 1, and C-C motif chemokine ligand 3

10 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a pattern-recognition

11 Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), one of the scavenger rec

12 gulation (~1.5 fold) of oxidized low-density lipoprotein receptor-1 (LOX-1).

13 NA gemmed from alternative splicing of Lrp6 (lipoprotein receptor 6), a gene highly expressed in vess

14 These results identify control of lipoprotein receptor abundance by IDOL as a post-transcr

15 Mice deficient for the low-density lipoprotein receptor and Apobec-1 were studied as an age

16 Mice deficient for both the low-density lipoprotein receptor and Apobec-1 were studied at 30 wee

17 CIH down-regulated hepatic low-density lipoprotein receptor and HMG-CoA reductase expression in

18 mice, which are deficient in the low-density lipoprotein receptor and in which hypercholesterolemia i

19 ering, with the discovery of the low-density lipoprotein receptor and its physiology and not only the

20 over, they reveal an unexpected link between lipoprotein receptor and sphingolipid signaling that, in

21 hich promotes the degradation of low-density lipoprotein receptors and, therefore, the increased conc

22 h a t-PA receptor, most likely a low-density lipoprotein receptor, and a plasminogen receptor.

23 onger Sepp1 isoforms bind to the low density lipoprotein receptor apoER2, but the mechanism remains u

24 DH is caused by mutations in the low-density lipoprotein receptor, apolipoprotein B, or proprotein co

25 tified cholesterol uptake by the low-density lipoprotein receptor as essential for the growth of ALCL

26 Ubiquitous blocking of LRP1 or additional lipoprotein receptors by overexpressing receptor-associa

27 acrophage by modulating oxidized low-density lipoprotein receptor CD36, phagolysosomal maturation blo

28 Genetic deletion of a lipoprotein receptor, CD36, reduces macrophage lipid con

29 cassette transporter (atp), and low-density lipoprotein receptor chaperone (ldlr), that are under th

30 that the amino-terminal modular low-density lipoprotein receptor class A (LA) domains within HP14 ar

31 R-Cas9-based screen, we identify low-density lipoprotein receptor class A domain-containing 3 (LDLRAD

32 specific degradation of the LDL (low-density lipoprotein) receptor combined with a 10-week western di

33 -coenzyme A reductase, and human low-density lipoprotein receptor), compared to uninfected controls.

34 Five-week-old female low-density lipoprotein receptor deficient (LDL-R-/-) and C57BL/6J w

35 d aorta in atherosclerosis-prone low-density lipoprotein receptor deficient (Ldlr(-/-)) mice.

36 oth the Apoe(-/-) and Ldlr(-/-) (low-density lipoprotein receptor deficient) knockout strains, and th

37 Moreover, LDLR (low-density lipoprotein receptor) deficient animals transplanted wit

38 cted deletion of DNGR-1 in Ldlr (low-density lipoprotein receptor)-deficient mice (Ldlr(-/-)) signifi

39 a (o/fl)/ LC mice to atherogenic low-density lipoprotein receptor-deficient ( Ldlr(-/-)) mice; and by

40 Low-density lipoprotein receptor-deficient (Ldlr(-/-) ) mice were cr

41 c lesions from high-fat diet-fed low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice in a tim

42 radiated, atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice received

43 t cells in atherosclerosis-prone low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice, we show

44 and spleens of high-fat diet-fed low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice.

45 cells in atherosclerosis-prone, low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice.

46 nvading photoreceptors: the very low-density lipoprotein receptor-deficient (Vldlr(-/-) ) mouse.

47 were crossed into hyperlipidemic low-density lipoprotein receptor-deficient animals.

48 In a low-density lipoprotein receptor-deficient atherosclerotic mouse mod

49 Low-density lipoprotein receptor-deficient chimeric mice expressing

50 Herein, in low-density lipoprotein receptor-deficient hyperlipidemic and strept

51 ecreased hepatic inflammation in low-density lipoprotein receptor-deficient mice on a Western-type di

52 e response pathways in livers of low-density lipoprotein receptor-deficient mice on a Western-type di

53 evelopment of atherosclerosis in low-density lipoprotein receptor-deficient mice.

54 rosclerotic aortas obtained from low-density lipoprotein receptor-deficient mice.

55 the AngII-infused hyperlipidemic low-density lipoprotein receptor-deficient mouse (LDLR(-/-)) model,

56 sclerosis-susceptible Ldlr(-/-) (low-density lipoprotein receptor-deficient) mice is substantially hi

57 Eight-week-old male low-density-lipoprotein-receptor-deficient mice were subjected to 5/

58 o regulate IDOL expression and IDOL-mediated lipoprotein receptor degradation.

59 Lipid-siRNAs are targeted to lipoprotein receptor-enriched tissues, eliciting signifi

60 exin type 9 (PCSK9) binds to the low-density lipoprotein receptor, escorting it to its destruction in

61 onarily conserved pathway for the control of lipoprotein receptor expression and cellular lipid uptak

62 f lower hepatic mRNA editing and low-density lipoprotein receptor expression, and higher levels of ci

63 ing protein 2 and downregulating low-density lipoprotein receptor expression.

64 tein 1 (LRP1) is a member of the low density lipoprotein receptor family and plays important roles in

65 perone that binds LRP1 and other low density lipoprotein receptor family members in the endoplasmic r

66 eptor (VLDLR) is a member of the low-density lipoprotein receptor family that binds multiple ligands

67 tein structurally related to the low-density lipoprotein receptor family that displays a large lumina

68 f-function mutations in the LDL (low-density lipoprotein) receptor gene (LDLR) cause elevated levels

69 Brain lipoprotein receptors have been shown to regulate the me

70 Lipoprotein receptors have broad effects in both the dev

71 aising the expression of SREBP2, low-density lipoprotein receptor, HMGCo-A reductase, and the cholest

72 A significant role is established for lipoprotein receptors in sprouting and regeneration afte

73 tilisin kexin 9 (PCSK9) binds to low-density lipoprotein receptors, increasing serum LDL-C.

74 models of C57BL/6 wild-type and low density lipoprotein receptor knock-out (LDLR(-/-)) mice.

75 R/KR) mice are intercrossed with low density lipoprotein receptor knock-out mice (Ldlr(-/-)), they de

76 nd 31%, respectively, in fasting low-density lipoprotein receptor knockout (LDLR(-/-)) mice.

77 ECGs were measured in low-density lipoprotein receptor knockout (LDLr(-/-)), apolipoprotei

78 d PB-NLCs were investigated in a low density lipoprotein receptor knockout (LDLr-/-) mouse model, inc

79 n- (OVA-) sensitized C57BL/6 and low-density lipoprotein receptor knockout mice (LDLr(-/-)) for 5 wee

80 nesis by mPGES-1 deletion in the low-density lipoprotein receptor knockout mice (n=17-21).

81 In this study, we fed low-density lipoprotein receptor knockout mice a Western high-fat di

82 ve transfer of apop(ox)-DCs into low-density lipoprotein receptor knockout mice either before or duri

83 te T cell lipid composition and responses in lipoprotein receptor knockout mice even in the absence o

84 erosclerotic lesion formation in low-density lipoprotein receptor knockout mice.

85 herosclerosis development in the low-density lipoprotein receptor knockout mouse.

86 on a hyperlipidemic background (low-density lipoprotein receptor knockouts).

87 ts an atheroprotective action on low density lipoprotein receptor (LDL-r(-/-)) female mice, but, in c

88 planted into lethally irradiated low density lipoprotein receptor Ldlr(-/-) mice on an atherogenic di

89 bit recognition of oxLDL by KCs, low-density lipoprotein receptor (Ldlr(-/-) ) mice were immunized wi

90 to mice that do not express the low density lipoprotein receptor (Ldlr(-/-)), which are hyperlipidem

91 a Western-type diet and lacking low-density lipoprotein receptor (Ldlr(-/-)T39(-/-)) show decreased

92 oss-of-function mutations in the low-density lipoprotein receptor (LDLR) and homozygous familial hype

93 The apoE receptors low-density lipoprotein receptor (LDLR) and LDLR-related protein 1 (

94 owth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradatio

95 eduction in transcript levels of low-density lipoprotein receptor (LDLR) and of keratin genes known t

96 d glycosaminoglycans (sGAGs) and low-density lipoprotein receptor (LDLR) as host factors contributing

97 lly deficient iPSC utilizing the low-density lipoprotein receptor (LDLR) deficiency Familial Hypercho

98 Female low-density lipoprotein receptor (Ldlr) deficient mice with an XX or

99 ficiently blocked PCSK9-mediated low density lipoprotein receptor (LDLR) degradation in cell lines, i

100 n and receptors belonging to the low density lipoprotein receptor (LDLR) family, known to be involved

101 e polymorphism in exon 12 of the low-density lipoprotein receptor (LDLR) gene, rs688, has been associ

102 thionine beta-synthase (CBS) and low-density lipoprotein receptor (LDLr) genes were deficient (Ldlr(-

103 rol and an overexpression of the low-density lipoprotein receptor (LDLR) in pancreatic tumor cells.

104 Low-density lipoprotein receptor (LDLR) internalization clears chole

105 Hepatic abundance of the low-density lipoprotein receptor (LDLR) is a critical determinant of

106 The low-density lipoprotein receptor (LDLR) is a critical determinant of

107 e recently demonstrated that the low-density lipoprotein receptor (LDLR) is a major apoE receptor in

108 Therefore, the low-density lipoprotein receptor (LDLR) is a relevant target for del

109 The low density lipoprotein receptor (LDLR) is crucial for cholesterol h

110 Low-density lipoprotein receptor (LDLR) is involved in uptake of cho

111 osclerotic lesion macrophages of low-density lipoprotein receptor (Ldlr) knockout mice fed a Western

112 k3a/GSK3alpha-knockout mice with low-density lipoprotein receptor (Ldlr) knockout mice.

113 atients who already have reduced low-density lipoprotein receptor (LDLR) levels, such as those with h

114 regulation through modulation of low density lipoprotein receptor (LDLR) levels.

115 The hepatic low-density lipoprotein receptor (LDLR) pathway is essential for cle

116 The low-density lipoprotein receptor (LDLR) plays a pivotal role in clea

117 in type 9 (PCSK9), which reduces low-density lipoprotein receptor (LDLR) recycling and hence choleste

118 Low-density lipoprotein receptor (LDLR) rs6511720 A was significantl

119 Since the low-density lipoprotein receptor (LDLR) was recently identified as a

120 Low density lipoprotein receptor (LDLR) was shown to mediate clearan

121 ring NAPE-expressing bacteria to low-density lipoprotein receptor (Ldlr)(-/-) mice fed a Western diet

122 te that modulating levels of the low-density lipoprotein receptor (LDLR), a cell surface receptor tha

123 At low-density lipoprotein receptor (LDLR), carriers of rare non-synony

124 f the identified substrates, the low-density lipoprotein receptor (LDLR), ERdj5 is required not for d

125 N1), Occludin (OCLN), SR-BI, and low-density lipoprotein receptor (LDLR), function mainly at postatta

126 fied 2 nonsynonymous variants in low-density lipoprotein receptor (LDLR), namely p.G116S and p.R730W.

127 eptor molecules CD81, claudin-1, low-density lipoprotein receptor (LDLr), occludin, and SR-BI did not

128 lisin/kexin type 9 (PCSK9) binds low-density lipoprotein receptor (LDLR), preventing its recycling.

129 r the degradation of the hepatic low-density lipoprotein receptor (LDLR), which in turn regulates the

130 of-of-principle, we targeted the low-density lipoprotein receptor (Ldlr), which when deleted, leads t

131 poprotein E (apoE)-deficient and low-density lipoprotein receptor (LDLR)-deficient mice that produce

132 Low-density lipoprotein receptor (Ldlr)-knockout mice were transplan

133 oss-of-function mutations in the low-density lipoprotein receptor (LDLR).

134 and regulate its activity on the low-density lipoprotein receptor (LDLR).

135 LDL (low-density lipoprotein) receptor (LDLR) binds to its negative regul

136 a IDOL and inducible degrader of low-density lipoprotein receptor [LDLR]), with LDL cholesterol stati

137 a mechanism that is dependent on low-density lipoprotein receptors (LDLRs) and LDLR-related protein 1

138 concomitant with an increase in low density lipoprotein receptors (LDLRs).

139 PCSK9 levels, increased hepatic low-density lipoprotein receptor levels, and decreased plasma choles

140 Genetic analysis further revealed that the lipoprotein receptor LRP1 cell-autonomously controls PN

141 The lipoprotein receptor LRP1 is essential in neurons of the

142 Low-density lipoprotein receptors (LRPs) are present extensively on

143 The lipolysis-stimulated lipoprotein receptor (LSR) is the host cell receptor for

144 Here, we show that Lipolysis-stimulated lipoprotein receptor (LSR), a component of paracellular

145 ILDR1 was recently reported to be a lipoprotein receptor mediating the secretion of the fat-

146 s analyzed in aortic arches from low density lipoprotein receptor(-/-) mice consuming a high-choleste

147 P2X7(+/+) and P2X7(-/-) low density lipoprotein receptor(-/-) mice were fed a high-cholester

148 lanted into irradiated recipient low-density lipoprotein receptor(-/-) mice, and atherosclerosis was

149 rotein-deficient (apoE(-/-)) and low-density lipoprotein receptor negative (LDLR(-/-)) mice (0.05 mmo

150 DS AND Paradoxically, Ldlr(-/-) (low-density lipoprotein receptor null) mice deficient in miR-146a de

151 ion size was found in Ldlr(-/-) (low-density lipoprotein receptor null) mice transplanted with bone m

152 ed atherosclerosis in irradiated low-density lipoprotein receptor null-recipient mice and in apolipop

153 Low density lipoprotein receptor-null (Ldlr(-/-)) mice on a high-fat

154 Cre-IKKbeta-flox system rendered low density lipoprotein receptor-null mice resistant to vascular inf

155 ar smooth muscle lineage of male low-density lipoprotein receptor-null mice, a background susceptible

156 fied alpha2M delivers its misfolded cargo to lipoprotein receptors on macrophages and reduces Abeta1-

157 harboring targeting motifs from low-density lipoprotein receptor or neuron-glia cell-adhesion molecu

158 ermeability, whereas blockade of low-density lipoprotein receptors or exposed lysine residues resulte

159 rest to address drugs and contrast agents to lipoprotein-receptor-overexpressing cancer cells found i

160 ver provided that an intact apoE-low-density lipoprotein receptor pathway is present.

161 arizes our current understanding of the role lipoprotein receptors play in CNS function and AD pathol

162 In parallel, the low-density-lipoprotein receptor plays a predominant role in the cle

163 d dramatic reductions in hepatic low-density lipoprotein receptor protein and increased plasma low-de

164 n/kexin type 9 (PCSK9) regulates low density lipoprotein receptor protein levels by diverting it to l

165 netic ablation of Idol increases low-density lipoprotein receptor protein levels, which facilitates A

166 This points to macLRP1 being the only lipoprotein receptor regulating VWF levels.

167 in the liver can override other low-density lipoprotein receptor regulatory pathways leading to card

168 mation involves Frizzled4 (Fz4), low-density lipoprotein receptor related protein 5/6 (Lrp5/6), Tetra

169 very vehicle which encapsulated carnosine in lipoprotein receptor related protein-1 (LRP-1)-targeted

170 nalization of Abeta bound to the low density lipoprotein receptor related protein-1, a key Abeta clea

171 1/2), to their cognate receptor, low-density-lipoprotein-receptor related protein 6 (LRP6), in the pl

172 distinct receptors, namely, the low-density lipoprotein receptor-related protein (LRP) and cell surf

173 healthy donors was decreased after blocking lipoprotein receptor-related protein (LRP), a CRT recept

174 ously reported that RanBP9 binds low-density lipoprotein receptor-related protein (LRP), amyloid prec

175 pids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP).

176 Low density lipoprotein receptor-related protein (LRP1) mediates the

177 mber of the LDL receptor family, low-density lipoprotein receptor-related protein (LRP1).

178 Low-density lipoprotein receptor-related protein 1 (LRP-1) is a scav

179 Blocking low-density lipoprotein receptor-related protein 1 (LRP-1) receptor

180 We achieve this by targeting the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1) receptor.

181 hat an extracellular fragment of low-density lipoprotein receptor-related protein 1 (LRP-1) was prese

182 Low-density lipoprotein receptor-related protein 1 (LRP1) acts as th

183 MTS-5 is rapidly endocytosed via low density lipoprotein receptor-related protein 1 (LRP1) and degrad

184 ors for these secreted proteins, low-density lipoprotein receptor-related protein 1 (LRP1) and Integr

185 Here we show that the low-density lipoprotein receptor-related protein 1 (LRP1) controls t

186 clearance and signaling receptor low density lipoprotein receptor-related protein 1 (LRP1) in both pr

187 The low density lipoprotein receptor-related protein 1 (LRP1) is a membe

188 The low density lipoprotein receptor-related protein 1 (LRP1) is a ubiqu

189 Low density lipoprotein receptor-related protein 1 (LRP1) is indispe

190 Low-density lipoprotein receptor-related protein 1 (LRP1) regulates

191 Blocking studies of low-density lipoprotein receptor-related protein 1 (LRP1) suggested

192 lso requires the function of the low-density lipoprotein receptor-related protein 1 (LRP1), a major a

193 associated with its reduction in low-density lipoprotein receptor-related protein 1 (LRP1), an Abeta

194 d both alpha2M and its receptor, low-density lipoprotein receptor-related protein 1 (LRP1), in cultur

195 An Abeta clearance receptor, the low-density lipoprotein receptor-related protein 1 (LRP1), is abunda

196 ation of a SNX17 cargo receptor, low-density lipoprotein receptor-related protein 1 (LRP1), led to re

197 apoE and sAbeta compete for the low-density lipoprotein receptor-related protein 1 (LRP1)-dependent

198 arance by the scavenger receptor low density lipoprotein receptor-related protein 1 (LRP1).

199 he endocytic scavenger receptor, low-density lipoprotein receptor-related protein 1 (LRP1).

200 ecific interactions of apoE with low-density lipoprotein receptor-related protein 1 on brain vascular

201 We hypothesized that LRP1 (low-density lipoprotein receptor-related protein 1) expression is de

202 uptake was partially due to the low-density lipoprotein receptor-related protein 1.

203 s mRNA and protein expression of low density lipoprotein receptor-related protein 2 and alpha-synucle

204 ts with SNMG were retrospectively tested for lipoprotein receptor-related protein 4 (LRP4) antibodies

205 z+ agrin to both heparin and the low-density lipoprotein receptor-related protein 4 (LRP4) coreceptor

206 We demonstrate that the low-density lipoprotein receptor-related protein 4 (LRP4) is reduced

207 We explored the role of low-density lipoprotein receptor-related protein 4 (LRP4), a member

208 ain was impaired in mice lacking low-density lipoprotein receptor-related protein 4 (Lrp4), a protein

209 Low-density lipoprotein receptor-related protein 4 (Lrp4), a recepto

210 dentified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin

211 anabolic activity is enhanced by low-density lipoprotein receptor-related protein 4 (Lrp4), which fac

212 euromuscular synapses, and (iii) low-density lipoprotein receptor-related protein 4 (Lrp4), which res

213 ein acting downstream from agrin/low-density lipoprotein receptor-related protein 4 (LRP4)/MuSK, has

214 tified previously in vitro LRP4 (low-density lipoprotein receptor-related protein 4) as a facilitator

215 tein, which interacts with LRP4 (low-density lipoprotein receptor-related protein 4) to activate the

216 dentified novel functions of the low-density lipoprotein receptor-related protein 4-muscle-specific k

217 ditional knockout Wnt coreceptor low-density lipoprotein receptor-related protein 5 (Lrp5) and low-de

218 acid position (p.R1188W) in the low density lipoprotein receptor-related protein 5 (LRP5) gene segre

219 g ligand or receptors, including low-density lipoprotein receptor-related protein 5 (LRP5) gene.

220 yptophan hydroxylase 1 (Tph1) or low-density lipoprotein receptor-related protein 5 (Lrp5) that are i

221 y and show that the co-receptor, low-density lipoprotein receptor-related protein 5 (Lrp5), is requir

222 mice in which a mutation in the low-density lipoprotein receptor-related protein 5 Wnt coreceptor ca

223 , we observed elevated levels of low-density lipoprotein receptor-related protein 5/6 (LRP5/6) and Fr

224 d the Wnt-activated Frizzled and low-density lipoprotein receptor-related protein 5/6 receptors and p

225 it binds to the Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6) in cellula

226 contributions of Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6) in the vas

227 Low-density lipoprotein receptor-related protein 6 (LRP6) is a corec

228 Low-density lipoprotein receptor-related protein 6 (LRP6) is a Wnt c

229 The low-density lipoprotein receptor-related protein 6 (LRP6) is an esse

230 tor-related protein 5 (Lrp5) and low-density lipoprotein receptor-related protein 6 (Lrp6) mice in ad

231 induced by a constitutively active mutant of lipoprotein receptor-related protein 6 (LRP6) or beta-ca

232 n in Xenopus embryos, stimulated low-density lipoprotein receptor-related protein 6 (LRP6) phosphoryl

233 Interactions between Cav-1 and low-density lipoprotein receptor-related protein 6 (LRP6) were repor

234 Additionally, inhibition of low-density lipoprotein receptor-related protein 6 (LRP6) with eithe

235 is gene 2, as well as coreceptor low density lipoprotein receptor-related protein 6 (LRP6), are marke

236 including the expression of the Wnt receptor-lipoprotein receptor-related protein 6 (LRP6), phosphory

237 by binding to the Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6).

238 chaperone for the Wnt coreceptor low-density lipoprotein receptor-related protein 6 (LRP6).

239 s a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6).

240 Low-density lipoprotein receptor-related protein 6 encoding gene (LR

241 he E1E2 domain of Wnt coreceptor low-density lipoprotein receptor-related protein 6, Mab2F1, on canon

242 Fetal liver cells derived from low-density-lipoprotein receptor-related protein 6-deficient mice (L

243 uction of frizzleds (fz), arrow (low-density lipoprotein receptor-related protein [LRP] 5/6), disheve

244 e encoding WNT receptors (frizzled [FZD] and lipoprotein receptor-related protein [LRP] family member

245 pse number were mediated via the low-density lipoprotein receptor-related protein and subsequent Ca(2

246 (ADAM9), reticulon 4 (RTN4), and low-density lipoprotein receptor-related protein associated protein

247 The low-density lipoprotein receptor-related protein receptors 1 and 2 (

248 tutions within LRP1B, encoding a low-density lipoprotein receptor-related protein tied to both the NM

249 ound that the endocytic receptor low density lipoprotein receptor-related protein-1 (LRP-1) plays a m

250 eported to be endocytosed by the low-density lipoprotein receptor-related protein-1 (LRP-1).

251 The relationship between low-density lipoprotein receptor-related protein-1 (LRP1) and von Wi

252 We recently identified low density lipoprotein receptor-related protein-1 (LRP1) as a novel

253 s including mannose receptor and low-density lipoprotein receptor-related protein-1 (LRP1) have been

254 scular hypothesis, impairment of low-density lipoprotein receptor-related protein-1 (LRP1) in brain c

255 Low-density lipoprotein receptor-related protein-1 (LRP1) is a large

256 Low-density lipoprotein receptor-related protein-1 (LRP1) is an endo

257 giopep-2 (ANG), a ligand for the low-density lipoprotein receptor-related protein-1 (LRP1), has also

258 -aspartate receptor (NMDA-R) and low-density lipoprotein receptor-related protein-1 (LRP1), which fun

259 vation of beta1 integrin via the low density lipoprotein receptor-related protein-1 (LRP1), which lea

260 s dependent on the transmembrane low density lipoprotein receptor-related protein-1 (LRP1).

261 pathway that apparently requires low-density lipoprotein receptor-related protein-1 (LRP1).

262 mbospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1).

263 mbospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1).

264 Soluble low density lipoprotein receptor-related protein-1 (sLRP1) binds ~70

265 PDE1C interacts with low-density lipoprotein receptor-related protein-1 and PDGFRbeta, th

266 exin domain of MMP9 binds to the low-density lipoprotein receptor-related protein-1, triggers phospho

267 some-dependent degradation in an low-density lipoprotein receptor-related protein-1-dependent manner.

268 DGFRbeta protein degradation via low-density lipoprotein receptor-related protein-1.

269 s and monocytes to MDSCs via the low-density lipoprotein receptor-related protein-2 (LRP2) receptor a

270 nd insulin sensitivity through a low-density lipoprotein receptor-related protein-2 (LRP2)-dependent

271 igand-binding antagonist for the low-density lipoprotein receptor-related proteins (LRPs), and siRNA-

272 a ligand for the WNT coreceptors low-density lipoprotein receptor-related proteins 5 and 6 (LRP-5 and

273 hese results complement our understanding of lipoprotein receptor-related proteins 5 and 6 (LRP5/6),

274 izzled 1-10 and the co-receptors low-density lipoprotein receptor-related proteins 5 and 6.

275 eceptor (FZD) and the coreceptor low-density lipoprotein-receptor-related protein 5 (LRP5).

276 how that the soluble form of the low-density lipoprotein receptor relative, LR11/SorLA (sLR11), suppr

277 rotein E receptor 2 and the very low density lipoprotein receptor, resulting in the phosphorylation o

278 itellogenin receptor Yolkless, a low density lipoprotein receptor superfamily member, occur; a functi

279 B type 1), encoded by the gene SCARB1, is a lipoprotein receptor that binds both high-density lipopr

280 Class B scavenger receptors (SR-B) are lipoprotein receptors that also mediate pathogen recogni

281 BI (SR-BI) and BII (SR-BII) are high-density lipoprotein receptors that recognize various pathogens,

282 th the RELN receptor VLDLR (very low-density lipoprotein receptor); this was confirmed by a RELN-bind

283 odies prevent the degradation of low density lipoprotein receptor, thus lowering serum levels of LDL-

284 venting the recirculation of the low-density lipoprotein receptor to the hepatocyte cell surface.

285 a 95-141) that separates the two low-density lipoprotein receptor type A (LDLR-A) domains does not af

286 Reelin signals via the lipoprotein receptors very low density lipoprotein recep

287 Activation of very low density lipoprotein receptor (VLDLR) and apolipoprotein E recept

288 a the lipoprotein receptors very low density lipoprotein receptor (VLDLR) and apolipoprotein E recept

289 n E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and is internalized by cell

290 d that miR-200c targets the very low density lipoprotein receptor (Vldlr) and its ligand reelin, whic

291 Receptor 2 (ApoER2) and the very low density lipoprotein receptor (VLDLR) are type I transmembrane pr

292 The very low density lipoprotein receptor (VLDLR) is a member of the low-dens

293 viously, we have shown that very low density lipoprotein receptor (VLDLR) is virtually absent in prea

294 The very-low-density lipoprotein receptor (VLDLR) negatively regulates Wnt si

295 ding through the receptors, Very low-density lipoprotein receptor (Vldlr), Apolipoprotein receptor 2

296 Very-low-density lipoprotein receptor (Vldlr), which is present in photor

297 another angiogenic model of very-low-density lipoprotein receptor (Vldlr)-deficient (Vldlr (-/-) ) mi

298 neovascularization and the very low density lipoprotein receptor (Vldlr)-knockout mouse].

299 apparent effect of hypoxia on HSPGs, whereas lipoprotein receptors (VLDLR and SR-B1) were transiently

300 an interaction with VLDLR (very low-density lipoprotein receptor), while the APOER2 signaling pathwa